World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
16463
World Ranking
2591
National Ranking
1235

Joan B. Geisbert publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Joan B. Geisbert sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 138 publications — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Joan B. Geisbert D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Joan B. Geisbert sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Joan B. Geisbert is affiliated with The University of Texas Medical Branch at Galveston in the United States. Their research primarily focuses on the field of Medicine, with a significant emphasis on Infectious Diseases.

Their work encompasses several subfields, including Infectious Diseases, Epidemiology, Modeling and Simulation, Radiology, Nuclear Medicine and Imaging, and Molecular Biology.

The scientist's research topics cover a range of areas related to viral infections, including Viral Infections and Outbreaks Research, Viral Infections and Vectors, SARS-CoV-2 and COVID-19 Research, COVID-19 Epidemiological Studies, Hepatitis B Virus Studies, COVID-19 Clinical Research Studies, and Viral Gastroenteritis Research and Epidemiology.

Joan B. Geisbert has published in various journals and venues, with frequent publications in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • Proceedings of the National Academy of Sciences
  • PLoS Neglected Tropical Diseases
  • Cell

Among their recent papers are the following:

  • Establishment of an African green monkey model for COVID-19 and protection against re-infection, 2020, Nature Immunology
  • Combination therapy protects macaques against advanced Marburg virus disease, 2021, Nature Communications
  • Establishment of an African green monkey model for COVID-19, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase, 2020, Virology Journal
  • A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease, 2022, Proceedings of the National Academy of Sciences

The scientist has collaborated frequently with several co-authors, including:

  • Thomas W. Geisbert
  • Krystle N. Agans
  • Robert W. Cross
  • Viktoriya Borisevich
  • Daniel J. Deer

Best Publications

  • Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

    Steven M. Jones;Heinz Feldmann;Heinz Feldmann;Ute Ströher;Ute Ströher;Joan B. Geisbert

  • Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

    Thomas W. Geisbert;Lisa E. Hensley;Tom Larsen;Howard A. Young

  • Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

    Nancy J. Sullivan;Thomas W. Geisbert;Joan B. Geisbert;Ling Xu

  • Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

    Thomas W. Geisbert;Amy Ch Lee;Marjorie Robbins;Joan B. Geisbert

  • Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

    Thomas W Geisbert;Lisa E Hensley;Peter B Jahrling;Tom Larsen

  • Evaluation of Immune Globulin and Recombinant Interferon-α2b for Treatment of Experimental Ebola Virus Infections

    Peter B. Jahrling;Peter B. Jahrling;Peter B. Jahrling;Thomas Geisbert;Thomas Geisbert;J. B. Geisbert;J. B. Geisbert;J. R. Swearengen;J. R. Swearengen

  • Effective post-exposure treatment of Ebola infection.

    Heinz Feldmann;Steven M Jones;Steven M Jones;Kathleen M Daddario-DiCaprio;Kathleen M Daddario-DiCaprio;Joan B Geisbert

  • Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus

    Thomas W. Geisbert;Joan B. Geisbert;Joan B. Geisbert;Anders Leung;Kathleen M. Daddario-DiCaprio;Kathleen M. Daddario-DiCaprio;Kathleen M. Daddario-DiCaprio

  • Development of a new vaccine for the prevention of Lassa fever.

    Thomas W Geisbert;Thomas W Geisbert;Steven Jones;Steven Jones;Elizabeth A Fritz;Amy C Shurtleff

  • Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference

    Thomas W. Geisbert;Lisa E. Hensley;Elliott Kagan;Erik Zhaoying Yu

  • Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys

    Wendelien B Oswald;Thomas W Geisbert;Kelly J Davis;Joan B Geisbert

  • CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

    Nancy J Sullivan;Lisa Hensley;Clement Asiedu;Thomas W Geisbert

  • Lassa Fever in Post-Conflict Sierra Leone

    Jeffrey G. Shaffer;Donald S. Grant;John S. Schieffelin;Matt L. Boisen

  • Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge

    Thomas W. Geisbert;Michael Bailey;Lisa Hensley;Clement Asiedu

  • Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.

    Nancy J Sullivan;Thomas W Geisbert;Joan B Geisbert;Devon J Shedlock

  • Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates.

    Thomas W. Geisbert;Kathleen M. Daddario-DiCaprio;Mark G. Lewis;Joan B. Geisbert

  • Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates

    Emily P. Thi;Chad E. Mire;Amy C. H. Lee;Joan B. Geisbert

  • Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses

    Peter Pushko;Joan Geisbert;Michael Parker;Peter Jahrling

  • Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses

    Thomas W. Geisbert;Kathleen M. Daddario-DiCaprio;Kathleen M. Daddario-DiCaprio;Joan B. Geisbert;Joan B. Geisbert;Douglas S. Reed

  • Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses

    P. B. Jahrling;J. Geisbert;J. R. Swearengen;G. P. Jaax

Frequent Co-Authors

Thomas W. Geisbert
Thomas W. Geisbert The University of Texas Medical Branch at Galveston
Heinz Feldmann
Heinz Feldmann National Institutes of Health
Lisa E. Hensley
Lisa E. Hensley National Institutes of Health
Steven M. Jones
Steven M. Jones University of Saskatchewan
Friederike Feldmann
Friederike Feldmann National Institutes of Health
Peter B. Jahrling
Peter B. Jahrling National Institute of Allergy and Infectious Diseases
Ute Ströher
Ute Ströher Centers for Disease Control and Prevention
Christopher C. Broder
Christopher C. Broder Uniformed Services University of the Health Sciences
Robert F. Garry
Robert F. Garry Tulane University
Peter B. Jahrling
Peter B. Jahrling National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Many professionals consider advancing their qualifications with specialized nursing programs. Affordable options are available, such as cheap psych np programs, which provide focused training in psychiatric care. These programs are ideal for those passionate about mental health and immunological impacts.

Nurse practitioners often evaluate salary expectations when choosing a career path. Understanding how much does a dnp make across states helps in making informed decisions about further education and potential earnings. Doctor of Nursing Practice (DNP) roles, especially in specialized fields, tend to offer competitive salaries linked to expertise and location.

Some clinicians aim to broaden their scope by transitioning roles. Resources such as fnp to acute care certification guides help Family Nurse Practitioners (FNPs) obtain certifications required to work with acute and critical care patients, which complements immunology knowledge in managing complex conditions.

For quicker career advancement, many turn to accelerated fnp programs designed to fast-track FNP qualifications. These intensive online programs allow professionals to efficiently build credentials while balancing work and study, facilitating timely entry into advanced healthcare roles.

Best Scientists Citing Joan B. Geisbert

Trending Scientists

Recently Published Articles